Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Te-An Lee
Institutions:
Institute of Biomedical Sciences, Academia Sinica,
Academia Sinica
Observed institutions:
National Taiwan University,
Institute of Biomedical Sciences, Academia Sinica,
Academia Sinica
ORCID:
0000-0003-1987-2653
Observed ORCID:
0000-0003-1987-2653
OpenAlex ID:
A5034647547
Biomarkers in long COVID-19: A systematic review
2023
·
Yun-Ju Lai
, Shou-Hou Liu
, et al.
·
Frontiers in Medicine
·
267
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro
2021
·
Hsiang-Chi Huang
, Yun-Ju Lai
, et al.
·
EBioMedicine
·
63
PDF
Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
·
Cancer Research
·
46
PDF
Regulation of PD-L1 glycosylation and advances in cancer immunotherapy
2025
·
Te-An Lee
, En-Yun Tsai
, et al.
·
Cancer Letters
·
31
Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail.
2021
·
Yun-Ju Lai
, Chi-Hong Chao
, et al.
·
PubMed
·
29
Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis.
2021
·
Hsiang-Chi Huang
, Chun-Che Liao
, et al.
·
Europe PMC (PubMed Central)
·
16
Deglycosylation of SLAMF7 in breast cancers enhances phagocytosis.
2022
·
Shih-Han Wang
, Wen-Cheng Chou
, et al.
·
PubMed
·
12
Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review
2022
·
Te-An Lee
, Shih-Han Wang
, et al.
·
Translational Oncology
·
5
PDF
Blood-based biomarkers associated with long COVID: an updated systematic review
2026
·
Yun-Ju Lai
, Te-An Lee
, et al.
·
BMC Infectious Diseases
Table S1 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Table S1 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Figure S1 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Data from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Data from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Figure S1 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Table S2 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Table S2 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Abstract 5279: Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review
2022
·
Yun-Ju Lai
, Te-An Lee
, et al.
·
Cancer Research
Show more works
View as search
Works count:
18
Citation count:
469
H-index:
7
I10-index:
7
Year
Topic
Type
